ICSI will lead in vitro fertilization sales through 2036 with 55.0% share of the procedure segment in 2026. Fertility clinics hold 65.0% share of the end-user segment in 2026. The market was valued at USD 1.17 billion in 2025 and is projected to reach USD 3.80 billion by 2036.